Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling

L. Bumba, D. Laaf, V. Spiwok, L. Elling, V. Křen, P. Bojarová,

. 2018 ; 19 (2) : . [pub] 20180126

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033362

Galectin-3 (Gal-3) is recognized as a prognostic marker in several cancer types. Its involvement in tumor development and proliferation makes this lectin a promising target for early cancer diagnosis and anti-cancer therapies. Gal-3 recognizes poly-N-acetyllactosamine (LacNAc)-based carbohydrate motifs of glycoproteins and glycolipids with a high specificity for internal LacNAc epitopes. This study analyzes the mode and kinetics of binding of Gal-3 to a series of multivalent neo-glycoproteins presenting complex poly-LacNAc-based oligosaccharide ligands on a scaffold of bovine serum albumin. These neo-glycoproteins rank among the strongest Gal-3 ligands reported, with Kd reaching sub-nanomolar values as determined by surface plasmon resonance. Significant differences in the binding kinetics were observed within the ligand series, showing the tetrasaccharide capped with N,N'-diacetyllactosamine (LacdiNAc) as the strongest ligand of Gal-3 in this study. A molecular model of the Gal-3 carbohydrate recognition domain with docked oligosaccharide ligands is presented that shows the relations in the binding site at the molecular level. The neo-glycoproteins presented herein may be applied for selective recognition of Gal-3 both on the cell surface and in blood serum.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033362
003      
CZ-PrNML
005      
20181010124903.0
007      
ta
008      
181008s2018 sz f 000 00|eng||
009      
AR
024    7_
$a 10.3390/ijms19020372 $2 doi
035    __
$a (PubMed)29373511
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bumba, Ladislav $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. bumba@biomed.cas.cz.
245    10
$a Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling / $c L. Bumba, D. Laaf, V. Spiwok, L. Elling, V. Křen, P. Bojarová,
520    9_
$a Galectin-3 (Gal-3) is recognized as a prognostic marker in several cancer types. Its involvement in tumor development and proliferation makes this lectin a promising target for early cancer diagnosis and anti-cancer therapies. Gal-3 recognizes poly-N-acetyllactosamine (LacNAc)-based carbohydrate motifs of glycoproteins and glycolipids with a high specificity for internal LacNAc epitopes. This study analyzes the mode and kinetics of binding of Gal-3 to a series of multivalent neo-glycoproteins presenting complex poly-LacNAc-based oligosaccharide ligands on a scaffold of bovine serum albumin. These neo-glycoproteins rank among the strongest Gal-3 ligands reported, with Kd reaching sub-nanomolar values as determined by surface plasmon resonance. Significant differences in the binding kinetics were observed within the ligand series, showing the tetrasaccharide capped with N,N'-diacetyllactosamine (LacdiNAc) as the strongest ligand of Gal-3 in this study. A molecular model of the Gal-3 carbohydrate recognition domain with docked oligosaccharide ligands is presented that shows the relations in the binding site at the molecular level. The neo-glycoproteins presented herein may be applied for selective recognition of Gal-3 both on the cell surface and in blood serum.
650    _2
$a vazebná místa $7 D001665
650    _2
$a galektin 3 $x chemie $x metabolismus $7 D037502
650    _2
$a glykoproteiny $x chemie $x farmakologie $7 D006023
650    _2
$a lidé $7 D006801
650    _2
$a laktosa $x analogy a deriváty $x chemie $7 D007785
650    _2
$a ligandy $7 D008024
650    12
$a simulace molekulového dockingu $7 D062105
650    _2
$a vazba proteinů $7 D011485
650    _2
$a sérový albumin hovězí $x chemie $7 D012710
655    _2
$a časopisecké články $7 D016428
700    1_
$a Laaf, Dominic $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. d.laaf@biotec.rwth-aachen.de.
700    1_
$a Spiwok, Vojtěch $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 3, 16628 Prague 6, Czech Republic. Vojtech.Spiwok@vscht.cz.
700    1_
$a Elling, Lothar $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. l.elling@biotec.rwth-aachen.de.
700    1_
$a Křen, Vladimír $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. kren@biomed.cas.cz.
700    1_
$a Bojarová, Pavla $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. bojarova@biomed.cas.cz.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 19, č. 2 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29373511 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181010125352 $b ABA008
999    __
$a ok $b bmc $g 1340888 $s 1030356
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 19 $c 2 $e 20180126 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...